BREAKING NEWS
Multiple people shot in Baltimore in the US, armed suspects remain at large... ... More soon
Close

Expert 'too ashamed' to tell truth about insider trading

Last updated 10:14 22/01/2014

Relevant offers

World

Australia clamps down on misleading consumer reviews, but rules differ here ANZ blinked first in settlement with billionaires Pankaj and Radhika Oswal US grants Airbus, Boeing a chance to sell airplanes to Iran McLaren steers away from Apple buyout rumours US Fed holds off on raising interest rates, leaves them just above zero Blow for Uber as Finnish court orders two drivers to give up earnings UK's red phone boxes being turned into micro-offices Oops! Saudia Airlines flight crew's botched job sparks hijack scare, which they mistakenly confirmed Fear that China debt bubble will burst That painting bought to flip? Yours for a fraction of the price

An Alzheimer's expert says he was too ashamed to be truthful when the FBI confronted him with claims he fed inside information to a hedge fund manager.

Sidney Gilman described his dealings with investigators on Tuesday to a Manhattan jury at the trial of former SAC Capital portfolio manager Mathew Martoma.

The government says the secrets were about a clinical trial for a promising Alzheimer's drug.

The 81-year-old Gilman says he was "hoping it would go away" when he lied to the FBI in September 2011.

He says he had betrayed his colleagues, himself and his employer: the University of Michigan. He eventually signed a non-prosecution agreement and agreed to testify.

Prosecutors say Gilman's tips helped Martoma and SAC Capital earn US$250 million ($300 million) illegally.

Martoma has pleaded not guilty.

Ad Feedback

- AP

Special offers

Featured Promotions

Sponsored Content